Our first concern is that several proposed amendments could limit constitutional rights. Second, special regulations for a specific disease can’t be applied generally to all notifiable diseases. Finally, the proposed regulations resemble a haphazard cutting and pasting of the emergency regulations. It’s as though the drafters didn’t first read what’s already in place.
AuthorMichael Pepper
Director, Institute for Cellular and Molecular Medicine & SAMRC Extramural Unit for Stem Cell Research & Therapy, University of Pretoria.
Michael Pepper is Director of the Institute for Cellular and Molecular Medicine, Director of the South African Medical Research Council Extramural Unit for Stem Cell Research and Therapy, and a Research Professor in the Department of Immunology in the Faculty of Health Sciences at the University of Pretoria. He is also professeur associé in the Department of Genetic Medicine and Development in the Faculty of Medicine at the University of Geneva, Switzerland.
Michael obtained his MBChB in 1982 from the Faculty of Medicine at the University of Cape Town, and moved to Geneva in 1986, where he obtained his PhD in 1990, MD in 1992 and Privat Docent in 1997. He returned to South Africa in July 2004. Michael maintains research and teaching commitments in Pretoria and Geneva.
Michael has worked extensively in the field of clinically-oriented (translational) molecular cell biology and has made seminal contributions to understanding the mechanisms of angiogenesis and lymphangiogenesis. His current scientific interests are in the fields of cell and gene therapy and the human genome as well as the ethical, legal and social implications (ELSI) of work in these fields.
Michael led a consensus study for the Academy of Science of South Africa entitled “Human Genetics and Genomics in South Africa: Ethical, Legal and Social Implicaions” which was launched in December 2018, and is currently leading a project on the ELSI of gene therapy (including gene editing) in South Africa. He is President and Chairman of the Board of the South African Tissue Bank Association. Michael has also been working with the Department of Health on legislation pertaining to Chapter 8 of the National Health Act and regulations thereto since mid-2009. He was previously a member of the National Advisory Committee on Innovation which advises the Minister of Science and Technology.
Michael has more than 300 medical and scientific publications with and H-Index of 72/82 (Scopus/Google Scholar). He is a member of the Academy of Science of South Africa and has received a number of awards for his research including the South African Health Excellence Award for Scientific Excellence in 2019. Michael has been extensively involved in teaching at undergraduate and postgraduate levels, and has lectured widely on the international circuit. He is frequently solicited as a peer reviewer, and is currently on the editorial boards of Lymphatic Research and Biology and The Journal of Medical Law and Ethics. He interacts frequently with the media and writes for the lay press on scientific and medical matters.